{"id":"https://openalex.org/W2040918617","doi":"https://doi.org/10.1117/12.308147","title":"Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer","display_name":"Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer","publication_year":1998,"publication_date":"1998-05-19","ids":{"openalex":"https://openalex.org/W2040918617","doi":"https://doi.org/10.1117/12.308147","mag":"2040918617"},"language":"en","primary_location":{"id":"doi:10.1117/12.308147","doi":"https://doi.org/10.1117/12.308147","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.308147","pdf_url":null,"source":{"id":"https://openalex.org/S183492911","display_name":"Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE","issn_l":"0277-786X","issn":["0277-786X","1996-756X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315543","host_organization_name":"SPIE","host_organization_lineage":["https://openalex.org/P4310315543"],"host_organization_lineage_names":["SPIE"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SPIE Proceedings","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066084910","display_name":"Markus Frederic Renschler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Markus F. Renschler","raw_affiliation_strings":["Pharmacyclics, Inc. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics, Inc. (United States)","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112255195","display_name":"Alan R. Yuen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan R. Yuen","raw_affiliation_strings":["Stanford Univ. (United States)","Stanford University (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Univ. (United States)","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Stanford University (United States)","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111764574","display_name":"Timothy J. Panella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119499","display_name":"Thompson Cancer Survival Center","ror":"https://ror.org/02zhjb475","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210119499"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Panella","raw_affiliation_strings":["Thompson Cancer Survival Ctr. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thompson Cancer Survival Ctr. (United States)","institution_ids":["https://openalex.org/I4210119499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108229718","display_name":"Thomas J. Wieman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142740786","display_name":"University of Louisville","ror":"https://ror.org/01ckdn478","country_code":"US","type":"education","lineage":["https://openalex.org/I142740786"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Wieman","raw_affiliation_strings":["Univ. of Louisville (United States)","University of Louisville, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Louisville (United States)","institution_ids":["https://openalex.org/I142740786"]},{"raw_affiliation_string":"University of Louisville, United States","institution_ids":["https://openalex.org/I142740786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014753015","display_name":"Shona T. Dougherty","orcid":"https://orcid.org/0000-0001-8729-0060","observed_orcids":["https://orcid.org/0000-0001-8729-0060"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shona Dougherty","raw_affiliation_strings":["Univ. of California/Los Angeles (United States)","University of California Los Angeles UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of California/Los Angeles (United States)","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"University of California Los Angeles UNITED STATES","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072789687","display_name":"Laura J. Esserman","orcid":"https://orcid.org/0000-0001-9202-4568","observed_orcids":["https://orcid.org/0000-0001-9202-4568"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Esserman","raw_affiliation_strings":["Univ. of California/San Francisco (United States)","University of California San Francisco,  United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of California/San Francisco (United States)","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"University of California San Francisco,  United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113569653","display_name":"Masoud Panjehpour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119499","display_name":"Thompson Cancer Survival Center","ror":"https://ror.org/02zhjb475","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210119499"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masoud Panjehpour","raw_affiliation_strings":["Thompson Cancer Survival Ctr. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thompson Cancer Survival Ctr. (United States)","institution_ids":["https://openalex.org/I4210119499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049082000","display_name":"Scott W. Taber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142740786","display_name":"University of Louisville","ror":"https://ror.org/01ckdn478","country_code":"US","type":"education","lineage":["https://openalex.org/I142740786"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott W. Taber","raw_affiliation_strings":["Univ. of Louisville (United States)","University of Louisville, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Louisville (United States)","institution_ids":["https://openalex.org/I142740786"]},{"raw_affiliation_string":"University of Louisville, United States","institution_ids":["https://openalex.org/I142740786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035398414","display_name":"Victor H. Fingar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142740786","display_name":"University of Louisville","ror":"https://ror.org/01ckdn478","country_code":"US","type":"education","lineage":["https://openalex.org/I142740786"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor H. Fingar","raw_affiliation_strings":["Univ. of Louisville (United States)","University of Louisville, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Louisville (United States)","institution_ids":["https://openalex.org/I142740786"]},{"raw_affiliation_string":"University of Louisville, United States","institution_ids":["https://openalex.org/I142740786"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Elizabeth Lowe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Lowe","raw_affiliation_strings":["Pharmacyclics, Inc. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics, Inc. (United States)","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072642627","display_name":"Julie S. Engel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie S. Engel","raw_affiliation_strings":["Pharmacyclics, Inc. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics, Inc. (United States)","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110076874","display_name":"Bert L. Lum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bert Lum","raw_affiliation_strings":["Pharmacyclics, Inc. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics, Inc. (United States)","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011522761","display_name":"Kathryn W. Woodburn","orcid":"https://orcid.org/0000-0002-5213-9923","observed_orcids":["https://orcid.org/0000-0002-5213-9923"]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn W. Woodburn","raw_affiliation_strings":["Pharmacyclics, Inc. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics, Inc. (United States)","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012693512","display_name":"Wai\u2010Fung Cheong","orcid":"https://orcid.org/0000-0002-1912-2919","observed_orcids":["https://orcid.org/0000-0002-1912-2919"]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wai-Fung Cheong","raw_affiliation_strings":["Pharmacyclics, Inc. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics, Inc. (United States)","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091913369","display_name":"Richard A. Miller","orcid":"https://orcid.org/0000-0002-5696-2503","observed_orcids":["https://orcid.org/0000-0002-5696-2503"]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Miller","raw_affiliation_strings":["Pharmacyclics, Inc. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics, Inc. (United States)","institution_ids":["https://openalex.org/I4210133061"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":22.4768,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.99793175,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"3247","issue":null,"first_page":"35","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10957","display_name":"Photodynamic Therapy Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10957","display_name":"Photodynamic Therapy Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/photodynamic-therapy","display_name":"photodynamic therapy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/locally-recurrent-breast-cancer","display_name":"locally recurrent breast cancer","score":0.8299999833106995},{"id":"https://openalex.org/keywords/photosensitizers","display_name":"photosensitizers","score":0.9089999794960022},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.527999997138977},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5910000205039978},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.5370000004768372},{"id":"https://openalex.org/keywords/chest-wall-lesions","display_name":"chest wall lesions","score":0.6830000281333923},{"id":"https://openalex.org/keywords/radiotherapy-failure","display_name":"radiotherapy failure","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8328263759613037},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6376858949661255},{"id":"https://openalex.org/C2781323092","wikidata":"https://www.wikidata.org/wiki/Q1428072","display_name":"Photodynamic therapy","level":2,"score":0.6206278800964355},{"id":"https://openalex.org/C520551903","wikidata":"https://www.wikidata.org/wiki/Q1857","display_name":"Lutetium","level":4,"score":0.5914368033409119},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5680879950523376},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.5220292210578918},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47066056728363037},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.45140090584754944},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4299900531768799},{"id":"https://openalex.org/C2910279789","wikidata":"https://www.wikidata.org/wiki/Q1903551","display_name":"Recurrent breast cancer","level":4,"score":0.4135923385620117},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.36106812953948975},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34919220209121704},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33839496970176697},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32133522629737854},{"id":"https://openalex.org/C2779851234","wikidata":"https://www.wikidata.org/wiki/Q50690","display_name":"Oxide","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C531131001","wikidata":"https://www.wikidata.org/wiki/Q941","display_name":"Yttrium","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1117/12.308147","doi":"https://doi.org/10.1117/12.308147","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.308147","pdf_url":null,"source":{"id":"https://openalex.org/S183492911","display_name":"Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE","issn_l":"0277-786X","issn":["0277-786X","1996-756X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315543","host_organization_name":"SPIE","host_organization_lineage":["https://openalex.org/P4310315543"],"host_organization_lineage_names":["SPIE"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SPIE Proceedings","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1973333786","https://openalex.org/W1996836803","https://openalex.org/W2010326145","https://openalex.org/W2033552503","https://openalex.org/W2089514388","https://openalex.org/W2254321654"],"related_works":["https://openalex.org/W2039375086","https://openalex.org/W1992600137","https://openalex.org/W2297120766","https://openalex.org/W1989512282","https://openalex.org/W1985548503","https://openalex.org/W4233290476","https://openalex.org/W1973333786","https://openalex.org/W2157399488","https://openalex.org/W2047308122","https://openalex.org/W3005653382"],"abstract_inverted_index":{"Photodynamic":[0],"therapy":[1,258],"(PDT)":[2],"of":[3,13,17,21,95,147,161,177,244,262],"locally":[4,72,118,263],"recurrent":[5,73,119,264],"breast":[6,74,120,265],"cancer":[7,75,121],"has":[8,224],"been":[9,193,225],"limited":[10],"to":[11,109,195,203,214,247],"treatment":[12,27,135,233,261],"small":[14],"lesions":[15,122,178],"because":[16],"non-":[18],"selective":[19],"necrosis":[20,146],"adjacent":[22],"normal":[23,148],"tissues":[24,149],"in":[25,57,63,69,112,133,141,150,159,217,252,273],"the":[26,134,151,232,242,260,274],"field.":[28],"Lutetium":[29],"Texaphyrin":[30],"(PCI-0123,":[31],"Lu-Tex)":[32],"is":[33,41],"a":[34,58,207],"photosensitizer":[35],"with":[36,71,76,117,175],"improved":[37],"tumor":[38],"localization":[39],"that":[40],"activated":[42],"by":[43,88],"732":[44],"nm":[45],"light,":[46],"which":[47],"can":[48],"penetrate":[49],"through":[50],"larger":[51],"tumors.":[52],"We":[53],"have":[54,80,192,228,255],"evaluated":[55],"Lu-Tex":[56,86,103,245],"Phase":[59,66,101,188,276],"I":[60],"trial":[61,68],"and":[62,139,222],"an":[64],"ongoing":[65,275],"II":[67,277],"women":[70,253],"large":[77,248],"tumors":[78],"who":[79,254],"failed":[81,256],"radiation":[82,257],"therapy.":[83],"Patients":[84,227],"received":[85],"intravenously":[87],"rapid":[89],"infusion":[90],"3":[91],"hours":[92],"before":[93],"illumination":[94],"cutaneous":[96],"or":[97],"subcutaneous":[98],"lesions.":[99],"In":[100,187],"I,":[102],"doses":[104],"were":[105,123,131,157,219],"escalated":[106],"from":[107,201],"0.6":[108],"7.2":[110],"mg/kg":[111,130,205],"7":[113],"cohorts.":[114],"Sixteen":[115],"patients":[116,163,191],"treated.":[124],"Dose":[125],"limiting":[126],"toxicities":[127],"above":[128],"5.5":[129],"pain":[132,230],"field":[136,153],"during":[137],"therapy,":[138],"dysesthesias":[140],"light":[142],"exposed":[143],"areas.":[144],"No":[145],"treated":[152,220],"was":[154],"noticed.":[155],"Responses":[156],"observed":[158],"60%":[160],"evaluable":[162],"[n":[164],"equals":[165,181],"15,":[166],"27%":[167],"complete":[168],"remission":[169,173],"(CR),":[170],"33%":[171],"partial":[172],"(PR)],":[174],"63%":[176],"responding":[179],"(n":[180],"73:":[182],"45%":[183],"CR,":[184],"18%":[185],"PR).":[186],"II,":[189],"25":[190],"studied":[194],"date,":[196],"receiving":[197],"two":[198],"treatments":[199],"ranging":[200],"1.0":[202],"3.0":[204],"at":[206,231],"21":[208],"day":[209],"interval.":[210],"Treatment":[211,267],"fields":[212],"up":[213],"480":[215],"cm2":[216],"size":[218],"successfully":[221],"activity":[223],"observed.":[226],"experienced":[229],"site":[234],"but":[235],"no":[236],"tissue":[237],"necrosis.":[238],"These":[239],"studies":[240],"demonstrate":[241],"feasibility":[243],"PDT":[246],"chest":[249],"wall":[250],"areas":[251],"for":[259],"cancer.":[266],"conditions":[268],"are":[269],"currently":[270],"being":[271],"optimized":[272],"trials.":[278]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}